Column Group LLC Long-Term Concentrated

CIK: 0001833486 · Show all filings

Period: Q3 2023 (← Previous) (Next →)

Filing Date: Nov 13, 2023

Total Value ($000): $150,609 (100.0% shares, 0.0% debt)

Holdings (7)

— RAPT Therapeutics Inc 29.6%

Value ($000) $44,552 Shares 2,680,621 Est. Cost $19.03 Unrealized —

RVMD Revolution Medicines Inc 22.6%

Value ($000) $34,064 Shares 1,230,641 Est. Cost $34.24 Unrealized -13.4%

TNYA Tenaya Therapeutics, Inc. 15.9%

Value ($000) $23,971 Shares 9,400,290 Est. Cost $21.49 Unrealized -80.5%

ORIC ORIC Pharmaceuticals Inc. 14.3%

Value ($000) $21,587 Shares 3,568,181 Est. Cost $28.69 Unrealized -71.4%

— NGM Biopharmaceuticals Inc 12.9%

Value ($000) $19,406 Shares 18,136,735 Est. Cost $27.77 Unrealized —

— Surrozen, Inc. 3.1%

Value ($000) $4,613 Shares 9,414,795 Est. Cost $6.84 Unrealized —

— eFFECTOR Therapeutics Inc 1.6%

Value ($000) $2,415 Shares 4,026,224 Est. Cost $14.05 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	RAPT Therapeutics Inc	2,680,621	$44,552	29.6%	$19.03	—	COM	75382E109
RVMD	Revolution Medicines Inc	1,230,641	$34,064	22.6%	$34.24	-13.4%	COM	76155X100
TNYA	Tenaya Therapeutics, Inc.	9,400,290	$23,971	15.9%	$21.49	-80.5%	COM	87990A106
ORIC	ORIC Pharmaceuticals Inc.	3,568,181	$21,587	14.3%	$28.69	-71.4%	COM	68622P109
—	NGM Biopharmaceuticals Inc	18,136,735	$19,406	12.9%	$27.77	—	COM	62921N105
—	Surrozen, Inc.	9,414,795	$4,613	3.1%	$6.84	—	COM	86889P109
—	eFFECTOR Therapeutics Inc	4,026,224	$2,415	1.6%	$14.05	—	COM	28202V108